The 5,10-methenyltetrahydrofolate (5,10-CH=H 4 folate) synthetase catalyses the physiologically irreversible formation of 5,10-CH=H 4 folate from 5-formyltetrahydrofolate (5-HCO-H 4 folate) and ATP. It is not clear how (or if) 5-HCO-H 4 folate is formed in vivo. Using a spectrophotometric assay for 5-HCO-H 4 folate, human recombinant 5,10-CH=H 4 folate cyclohydrolase, which catalyses the hydrolysis of 5,10-CH=H 4 folate to 10-HCO-H 4 folate, was previously shown to catalyse inefficiently the formation of 5-HCO-H 4 folate at pH 7.3 [Pelletier and MacKenzie (1996) Bioorg. Chem. 24, [220][221][222][223][224][225][226][227][228]. In the present study, we report that (i) the human cyclohydrolase enzyme catalyses the conversion of 10-HCO-/5,10-CH=H 4 folate into 5-HCO-H 4 folate (it is also chemically formed) at pH 4.0-7.0; (ii) rat liver has a very low capacity to catalyse the formation of 5-HCO-H 4 folate when compared with the traditional activity of 5,10-CH=H 4 folate cyclohydrolase and the activity of the 5,10-CH=H 4 folate synthetase; and (iii) a substantial amount of 5-HCO-H 4 folate reported to be present in rat liver is chemically formed during analytical procedures. We conclude that (i) the cyclohydrolase represents some of the capacity of rat liver to catalyse the formation of 5-HCO-H 4 folate; (ii) the amount of 5-HCO-H 4 folate reported to be present in rat liver is overestimated (liver 5-HCO-H 4 folate content may be negligible); and (iii) there is little evidence that 5-HCO-H 4 folate inhibits one-carbon metabolism in mammals.
INTRODUCTION
The 5,10-methenyltetrahydrofolate (5,10-CH=H 4 folate) synthetase (EC 6.3.3.2) catalyses the formation of 5,10-CH=H 4 folate from 5-formyltetrahydrofolate (5-HCO-H 4 folate) and ATP [1] . However, it is not known how 5-HCO-H 4 folate is formed in vivo. No enzyme has been identified which catalyses the transfer of the 5-formyl group; therefore, the role of 5-HCO-H 4 folate in one-carbon metabolism is not clear. Pelletier and MacKenzie [2] developed a spectrophotometric assay for 5-HCO-H 4 folate and showed that 5,10-CH=H 4 folate cyclohydrolase (EC 3.5.4.9) catalyses the formation of (6S)-5-HCO-H 4 folate from (6R)-10-formyltetrahydrofolate (10-HCO-H 4 folate) at pH 7.3. However, the enzyme's catalytic efficiency for 5-HCO-H 4 folate formation is very poor when compared with the catalysis of the reversible hydrolysis of 5,10-CH=H 4 folate to 10-HCO-H 4 folate. Using this assay, we investigated whether the cyclohydrolase also catalyses the formation of 5-HCO-H 4 folate under mildly acidic conditions that resemble the environment of subcellular organelles (e.g. lysosomes), and in rat liver homogenate at neutral pH. We hypothesized that acidic subcellular organelles facilitate the formation of 5-HCO-H 4 folate by sequestering it from the 5,10-CH=H 4 folate synthetase. The assay for 5-HCO-H 4 folate was also used to investigate whether the 5-HCO-H 4 folate, identified previously in rat liver, was actually formed chemically from 10-HCO-H 4 folate and/or 5,10-CH=H 4 folate during analytical procedures.
MATERIALS AND METHODS
(6S)-5-HCO-H 4 folate was a gift from Lederle Laboratories (Pearle River, NY, U.S.A.) and was used to prepare (6R)-5,10-Abbreviations used: 5-HCO-H 4 folate, 5-formyltetrahydrofolate; 5,10-CH=H 4 folate, 5,10-methenyltetrahydrofolate; TCA, trichloroacetic acid. 1 To whom correspondence should be addressed (e-mail jwrainey@uab.edu).
CH=H 4 folate solutions as described previously [3] . When stock solutions of 5,10-CH=H 4 folate in 0.01 M H 2 SO 4 were diluted, the cyclohydrolase and/or the buffer catalyses its conversion into equilibrium concentrations of 10-HCO-H 4 folate. Thus these solutions are referred to as 10-HCO-/5,10-CH=H 4 folate.
The bifunctional 5,10-CH=H 4 folate cyclohydrolase/5,10-methylenetetradydrofolate dehydrogenase (EC 3.5.4.9/EC 1.5.1.5) was prepared as described previously and stored at − 20
• C in a buffer containing 50 mM phosphate (pH 7.3), 35 mM 2-mercaptoethanol, 7 mM NADP, 1 mM benzamidine and 20 % (v/v) glycerol [4] . The protein concentration in the stock solution was 0.5 mg/ml, which contained 15 units of the dehydrogenase activity/ml (1 unit = 1 µmol of product/min). The stock enzyme solution was thawed and diluted into the reaction buffer containing 50 mM acetate (pH 4.0, 4.5 or 5.0) or 50 mM phosphate (pH 6.0, 6.5 or 7.0) and 5.0 mM ascorbic acid. A nonenzymically catalysed reaction was also performed. Fresh, frozen (− 70
• C) rat liver was homogenized in 3 vol. (w/v) of 50 mM phosphate (pH 7.0), centrifuged at 3200 g for 10 min at 5
• C and a supernatant was used as a source of enzymes.
An assay of 5-HCO-H 4 folate developed by Pelletier and MacKenzie [2] was slightly modified. Aliquots of 0.5 ml of the reaction solutions were mixed with 0.5 ml of 1.0 M sodium acetate buffer (pH 3.3) or 0.5 ml of 7 % (w/v) aqueous trichloroacetic acid (TCA). The former solution was kept undisturbed for 10 min. The latter solution was heated at 100
• C for 90 s and cooled to room temperature (23 • C). Both solutions were centrifuged at 3000 g for 5 min and the absorbance at 356 nm (A 356 ) was measured in the supernatant and compared with similarly treated blank (i.e. buffer with or without enzyme). When the rat liver preparation was used, both the acetate and TCA The decrease in A 356 ( ε = 2.5 × 10 4 M −1 · cm −1 ) was used as an assay for the cyclohydrolase-catalysed formation of 10-HCO-H 4 folate from 5,10-CH=H 4 folate. Initial concentration of 5,10-CH=H 4 folate was 50 µM in 50 mM potassium phosphate (pH 7.0) and 5 mM ascorbate. The above assay for 5-HCO-H 4 folate was used to assay rat liver 5,10-CH=H 4 folate synthetase in 50 mM potassium phosphate (pH 7.0), 5 mM ascorbate, 10 mM MgCl 2 , 200 µM ATP and 100 µM 5-HCO-H 4 folate. Appropriate blanks for these assays contained all components except the enzyme source or the folate. Two protein concentrations (differing by a factor of two) were used to assay each of the above activities.
The pseudo-first-order rate constants for the formation of 5-HCO-H 4 folate from 10-HCO-/5,10-CH=H 4 folate were estimated by measuring the slope of a plot of In A 356 (acetate) versus time. A concentrated solution of 5,10-CH=H 4 folate (pH 2.5) was diluted into each buffer (containing 5 mM ascorbate) to obtain a final concentration of approx. 100 µM. Because of the lability of 10-HCO-H 4 folate (i.e. pH 7) at 100
• C, only one or two reaction halflife (t 1/2 ) values could be measured at this temperature before a departure from first-order kinetics was apparent.
The assay for 5-HCO-H 4 folate was applied for the extraction of folates from rat liver, in duplicate experiments, using published methods. 10-HCO-/5,10-CH=H 4 folate (0.1-1.0 mM) in 50 mM potassium phosphate (pH 7.2) was mixed with the same amount of extraction buffer as for the rat liver. The entire extraction and work-up procedure was then followed. A control sample was treated identically, with the exception that its temperature was maintained at 0
• C for the entire extraction and work-up procedures. In this analysis, the 10-HCO-/5,10-CH=H 4 folate reported was assumed to be the source of 5-HCO-H 4 folate. The hydrolysis of 10-HCO-/5,10-CH=H 4 folate to 5-HCO-H 4 folate will be pseudo first order; therefore, the fraction of the reactant converted into the product is independent of the initial concentration of the reactant. If 'F' is the amount (or percentage of total folate) of 10-HCO-/5,10-CH=H 4 folate reported and 'fr' is the fraction of 10-HCO-/5,10-CH=H 4 folate remaining (i.e. the fraction that has not been converted into 5-HCO-H 4 folate) after the extraction and work-up procedures, the amount of 5-HCO-H 4 folate formed chemically is given by the following equation: Table 1 are the estimated percentage of in vitro conversion of 10-HCO-/5,10-CH=H 4 folate into 5-HCO-H 4 folate that occurred during the analytical procedures and the newly estimated amount of 5-HCO-H 4 folate present. Individual procedures have been briefly described above and the results are presented in Table 1 .
The K m value of the cyclohydrolase for 10-HCO-/5,10-CH=H 4 folate was estimated using the EZ-Fit program (E.I. DuPont de Nemore, Wilmington, DE, U.S.A.). This program uses a non-linear regression fit of the data to the Michaelis-Menten equation.
RESULTS
The assay for 5-HCO-H 4 folate at pH 7.0 and 4.0 and in the presence of 10-HCO-/5,10-CH=H 4 folate is shown in Figure 1 . The assay worked well with a 0.5 ml sample when the buffer concentration was 50 mM. For higher concentrations, the sample volume was decreased and water was added to increase the volume up to 0. and 6.1 (+ − 2.8) × 10 −7 respectively at 23 • C and pH 7.0. In rat liver homogenate, the ratio of the specific activity of the cyclohydrolase to that for the formation of 5-HCO-H 4 folate was 2.0 × 10 4 . The assay for 5-HCO-H 4 folate was used to determine the amount of 5-HCO-H 4 folate which was formed during the analytical procedures as described in published reports [6] [7] [8] . We used a 50 mM phosphate buffer (pH 7.2) containing the 10-HCO-/ 5,10-CH=H 4 folate in an attempt to simulate the intracellular pH and buffering capacity in the liver. This is probably conservative since the intracellular phosphorus and amino acid residue concentrations are approx. 0.1 and 2.1 M respectively in rat liver [5] . Wilson and Horne [6] extracted rat liver by heating Hepes/Ches buffer (containing ascorbate and 2-mercaptoethanol; All points represent means for three experiments. ᭹, pH 6.0; , pH 6.5; , pH 7.0. Experiments were performed in 50 mM potassium phosphate buffer as described in the caption to Figure 1 . Open symbols and inset imply the same as for Figure 2 . Error bars and lines are described in Figure 2 . pH 7.85) at 100
• C for 10 min, then treated with γ -glutamyl hydrolase in phosphate buffer (pH 7.0) for 3 h at 37
• C followed by another heating for 5 min at 100
• C. As shown in Table 1 , most of the reported 5-HCO-H 4 folate would be formed chemically from 10-HCO-/5,10-CH=H 4 folate. The analytical procedures used by Tamura and co-workers [7, 8] differed slightly from that described by Wilson and Horne [6] . The liver folates were extracted with 2 vol. (instead of 10 vol.) of the same Hepes-Ches buffer and the extract was treated with 0.5 vol. (instead of 0.25 vol.) of rat serum γ -glutamyl hydrolase (T. Tamura, personal communication). Both of these alterations favoured more formation of 5-HCO-H 4 folate; thus, most of the 5-HCO-H 4 folate detected by Tamura and co-workers [7, 8] was probably formed chemically during the analytical procedures (Table 1 ). The newly calculated values for 5-HCO-H 4 folate in Table 1 led to an increase in the error (i.e. propagation of error) such that none of them was significantly greater than zero (P > 0.05, t test).
In the procedures described above, control experiments were performed involving the incubations at 0
• C (i.e. elimination of any heat treatment). This resulted in 2 % conversion of 10-HCO-/ 5,10-CH=H 4 folate into 5-HCO-H 4 folate. Because of the use of antioxidants, a loss of only 2 % of the total 10-HCO-/5,10-CH=H 4 folate plus 5-HCO-H 4 folate occurred during the brief treatments at 100
• C. Since heating at 37 and 100
• C are frequently used in the extraction and work-up of cellular folates for analysis, the pseudofirst-order rate constants and t 1/2 values were estimated for the formation of 5-HCO-H 4 folate from 10-HCO-/5,10-CH=H 4 folate and are shown in Table 2 . In general, the reaction is faster at lower pH and is slower in the Hepes/Ches buffer used by Wilson and Horne [6] when compared with the Tris and phosphate buffers.
DISCUSSION
The assay for 5-HCO-H 4 folate used in the present study was based on the immutable chemical and physical properties, permitting its detection even in the presence of 10-HCO-/5,10-CH=H 4 folate. The slow rate of the buffer-catalysed formation of 5-HCO-H 4 folate (Figures 2 and 3) is undoubtedly the reason why others [9, 10] believed that 5,10-CH=H 4 folate is exclusively hydrolysed to 10-HCO-H 4 folate at pH 6.5 at 25
• C. The apparent K m of the cyclohydrolase for 10-HCO-/5,10-CH=H 4 folate of 9.0 µM at pH 7.0 may be physiologically relevant. The curve depicting the progress of the reaction at pH 7.0 is not characteristic of a K m of 9.0 µM and suggests that the product, 5-HCO-H 4 folate, inhibits the cyclohydrolase (Figure 3) . The ratios of the specific activity of cyclohydrolase to that for the formation of 5-HCO-H 4 folate for the human enzyme and for rat liver homogenate are of similar orders of magnitude. This suggests that some of the capacity of rat liver to catalyse the formation of 5-HCO-H 4 folate is due to the activity of the cyclohydrolase. It is important to note that only the catalytic capacity of rat liver is measured and not the 5-HCO-H 4 folate formation in vivo.
Since low recoveries of 10-HCO-H 4 folate have been reported, it is not surprising for us to find that 10-HCO-/5,10-CH=H 4 folate was converted into 5-HCO-H 4 folate during the tissue extraction procedures. Recoveries of a 10-HCO-/5,10-CH=H 4 folate standard were reported to be only 69 % by Wilson and Horne [6] and even as low as 26 % by Belz and Nau [11] . Very substantial losses of 10-HCO-H 4 folate at pH 7.4 have been reported after only 5 min heating at 100
• C [12] . It is probable that the low recoveries of 10-HCO-/5,10-CH=H 4 folate reflect its conversion into 5-HCO-H 4 folate. Rebello [13] reported that 8.7 % of the total rat liver folates was 5-HCO-H 4 folate; however, the recovery of the folate standards added together was 55 % for 10-HCO-H 4 folate and 123 % for 5-HCO-H 4 folate, strongly suggesting that the chemical conversion of 10-HCO-/ 5,10-CH=H 4 folate into 5-HCO-H 4 folate occurred during the assay. Heating a solution of 10-HCO-H 4 folate at 100
• C for 10 min at pH 7.4 in the presence of ascorbate followed by HPLC and microbiological assay was reported to produce an 11 % conversion of it into 5-HCO-H 4 folate [14] . An unheated 10-HCO-H 4 folate stock solution even contained 7 % 5-HCO-H 4 folate, which was probably generated during storage [14] . The results in Figures 2 and 3 and Table 1 demonstrate that the formation of 5-HCO-H 4 folate from 10-HCO-/5,10-CH=H 4 folate in neutral or mildly acidic buffers can never be stopped, it can only be slowed down. The formation of 5-HCO-H 4 folate in procedures used to detect it, including tissue extractions, work-ups, sample storage on HPLC autosamplers etc., have led to its over-estimation.
Our results raise the question of whether 5-HCO-H 4 folate is actually present in mammalian tissues. It should be seriously considered that Rosenblatt et al. [15] and McMartin et al. [16] concluded that all the 5-HCO-H 4 folates they reported were formed chemically during the extraction of folates in cultured human fibroblasts and rat liver and that Duch et al. [17] did not detect 5-HCO-H 4 folate in rodent liver and kidney. These results are in agreement with our results in Table 2 . Others have reported that 10 % of the total rat and mouse liver folates is in the form of 5-HCO-H 4 folate [18, 19] . However, in a study of a single rat liver, the tissue extract (at pH 7.6) was heated for 20 min at 100
• C [18] . Furthermore, these studies [18, 19] reported that the liver pools of tetrahydrofolate and 5-methyltetrahydrofolate were 53-64 % and 17-24 % of the total folate respectively. These percentages are outside the values generally reported for these folates in rat and mouse liver [6] [7] [8] 12, 13, 16, 17, 20] . Thus there may be reasons to question the accuracy of these results. In any case, the spectrophotometric assay for 5-HCO-H 4 folate could be applied to extraction, work-up and analytical procedures to back correct for 5-HCO-H 4 folate formation from 10-HCO-/5,10-CH=H 4 folate. This approach may help clarify the results reported in the literature.
Is 5-HCO-H 4 folate efficiently biosynthesized and does it accumulate in mammalian liver after consumption of a large dose? Previous reports of active biosynthesis of 5-HCO-H 4 folate in rat liver ex vivo involved 100
• C treatments at pH 7.4 and 6.5, no separation of folate species followed by long-term microbiological assays [21] . These procedures would chemically convert 10-HCO-/5,10-CH=H 4 folate into 5-HCO-H 4 folate. Recent results are consistent with very little net accumulation of 5-HCO-H 4 folate following a dose. A dose of 5-HCO-H 4 folate (90 mg/kg) was given to mice. Only 6 h later, the dose started to accumulate or reach steady-state levels, and represented only approx. 1 % of the total liver folates [20] . This research group used specific enzyme-catalysed reactions to convert 5-HCO-H 4 folate into 5,10-CH=H 4 folate, which could then be detected by sensitive radiochemical methods [22] . A larger dose of 5-HCO-H 4 folate (400 mg/kg) has been administered to tumourbearing mice, and again 5-HCO-H 4 folate levels in liver essentially returned to baseline levels only after 6 h [23] . Heat treatments and work-up procedures probably created most of the baseline levels of 5-HCO-H 4 folate reported in this study [23] . The tumour, which contained barely detectable levels of the 5,10-CH=H 4 folate synthetase, did accumulate 5-HCO-H 4 folate in amounts approx. five times that of the normal liver at 6 h, and these results are likely to be real and emphasize the metabolic role of this synthetase in keeping 5-HCO-H 4 folate levels low [23] .
Our results indicate that the specific activity of the 5,10-CH=H 4 folate synthetase in rat liver is 900 times that of the catalytic capacity for the formation of 5-HCO-H 4 folate. Thus it is probable that any accumulation of 5-HCO-H 4 folate in vivo must occur at a cellular site sequestered from the 5,10-CH=H 4 folate synthetase, a cytosolic enzyme. Stokstad and co-workers [24] reported that the lysosomes of rat liver contain folate. This subcellular compartment would sequester folates from the 5,10-CH=H 4 folate synthetase, where cyclohydrolase-catalysed (or chemically catalysed) formation of 5-HCO-H 4 folate (albeit very small) could occur. We suggest that very small amounts of 5-HCO-H 4 folate could be formed and stored in lysosomes where it would be sequestered from (and therefore not affect) almost all enzymes of one-carbon metabolism. In support of this hypothesis, the capacity of lysosomes to internalize (and release) folates and to hydrolyse folyl polyglutamates has been shown to be one important feature for determining cellular folate polyglutamate chain length ( [25] and references therein). This metabolism is probably one reason why lysosomes contain folates [24] .
An alternative hypothesis to ours states that (i) serine hydroxymethyltransferase efficiently catalyses the formation of 5-HCO-H 4 folate in vivo from the putative substrate, 5,10-hydroxymethylenetetrahydrofolate, and (ii) a metabolic pool of 5-HCO-H 4 folate can substantially inhibit or bind to enzymes involved in one-carbon metabolism including folate-dependent enzymes of purine, pyrimidine and serine metabolism as well as 5,10-methylenetetrahydrofolate dehydrogenase and dihydrofolate reductase [26, 27] . We find that this hypothesis is not supported in mammalian liver because (i) the putative substrate, 5,10-hydroxymethylenetetrahydrofolate, does not exist or is not formed in significant amounts [3] ; (ii) the cyclohydrolase also contributes to the capacity of rat liver to catalyse 5-HCO-H 4 folate formation; (iii) the amount of 5-HCO-H 4 folate actually present in rat liver is overestimated (Table 1) ; and (iv) the activity of the 5,10-CH=H 4 folate synthetase greatly exceeds the activity required for the formation of 5-HCO-H 4 folate in rat liver and should prevent 5-HCO-H 4 folate accumulation in the cytoplasm [22, 23] . Furthermore, the absence of reported toxicity of highdose 5-HCO-H 4 folate in cancer patients and healthy subjects [28] [29] [30] is inconsistent with its postulated strong inhibition of one-carbon metabolism [26, 27] .
Thermodynamic equilibrium at pH 4.5-8 favours the formation of 5-HCO-H 4 folate from 10-HCO-/5,10-CH=H 4 folate, and it is difficult to imagine why there is any need for an efficient enzyme-catalysed formation. Since 5-HCO-H 4 folate must be formed continuously in vivo and without the activity of the 5,10-CH=H 4 folate synthetase, a majority of cytosolic tetrahydrofolates would eventually end up as a pool of metabolically inactive 5-HCO-H 4 folates. Thus there is a reason for the existence of the 5,10-CH=H 4 folate synthetase, as a salvage enzyme, keeping steady-state amounts of 5-HCO-H 4 folate in mammalian liver at negligible levels. The 5,10-CH=H 4 folate synthetase would also metabolize 5-HCO-H 4 folate formed during cooking and storage of food. Finally, 5-HCO-H 4 folate may actually accumulate and get stored in substantial amounts in non-mammalian cells, e.g. in the large acidic turgor vacuoles of plant cells.
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